Inspired by the in-vitro results, we further applied the orthotopic LLC transplantation model in vivo and found in the S655A group, metformin hardly suppressed lung cancer metastasis compared with PHF2-WT group (Fig. 6g–i). Here, PHF2 is linked to lung cancer.